Durability of anti-vascular endothelial growth factor agents in neovascular age-related macular degeneration

被引：0
|
作者：
Sivaprasad, Sobha [1 ]
机构：
[1] Moorfields Eye Hosp, NIHR Moorfields Biomed Res Ctr, London, England
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2021年 / 49卷 / 06期
关键词：
THERAPY;
D O I：
10.1111/ceo.13973
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：540 / 541
页数：2
相关论文
共 50 条
  • [41] Long-term Outcomes of Neovascular Age-related Macular Degeneration Treated with As Needed Anti-Vascular Endothelial Growth Factor Agents
    You, Qisheng
    Mendoza, Nadia
    Espina, Mark
    Alam, Mostafa
    Gaber, Raouf
    Kilic, Ilkay
    Freeman, William R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [42] Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration
    Cho, Han Joo
    Park, Sang Min
    Kim, Jaemin
    Nah, Seung Kwan
    Lee, Jihyun
    Lee, Dong Won
    Kim, Jong Woo
    ACTA OPHTHALMOLOGICA, 2021, 99 (04) : E540 - E546
  • [43] Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age-Related Macular Degeneration
    Bolling, James P.
    CURRENT DRUG THERAPY, 2012, 7 (02) : 90 - 95
  • [44] Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration
    Cho, Songhee
    Shin, Sang Jin
    Suh, Jae Kyung
    Tchoe, Hajin
    Kang, Min Joo
    Yang, Jangmi
    Jee, Donghyun
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (08): : 758 - 764
  • [45] Vascular remodelling after treatment with intravitreal anti-vascular endothelial growth factor in patients with neovascular age-related macular degeneration
    Kirkova, Radina
    Murgova, Snezhana
    Tanev, Ivan
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [46] Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration
    Ciulla, Thomas A.
    Rosenfeld, Philip J.
    CURRENT OPINION IN OPHTHALMOLOGY, 2009, 20 (03) : 166 - 174
  • [47] Anti-Vascular Endothelial Growth Factor Treatment Discontinuation and Interval in Neovascular Age-Related Macular Degeneration in the United States
    Bakri, Sophie J.
    Karcher, Helene
    Andersen, Stefen
    Souied, Eric H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 242 : 189 - 196
  • [48] Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
    Upasani, Deepa
    Dhingra, Narendra
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (09) : 2350 - 2354
  • [49] Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration
    Sridhar, Jayanth
    Hsu, Jason
    Shahlaee, Abtin
    Garg, Sunir J.
    Spirn, Marc J.
    Fineman, Mitchell S.
    Vander, James
    JAMA OPHTHALMOLOGY, 2016, 134 (04) : 437 - 443
  • [50] Effects of suspension of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration in clinical setting
    Matsubara, Hisashi
    Matsui, Yoshitsugu
    Miyata, Ryohei
    Ichio, Atsushi
    Chujo, Shinichiro
    Enomoto, Hiroko
    Sugimoto, Masahiko
    Kondo, Mineo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (06) : 1867 - 1876
12345